Penicillamine-induced degenerative dermatoses: report of a case and brief review of such dermatoses.
We describe a case of elastosis perforans serpiginosa with additional findings of degenerative skin changes. A 20-year-old man with hepatolenticular degeneration, under prolonged treatment with D-penicillamine, presented with a circular or serpiginous arrangement of nuchal papules. Histopathologically, transepidermal channels were accompanied by granulomatous reactions, with several giant cells engulfing elastic fibers. In addition to these findings of a typical elastosis perforans serpiginosa, we observed scar-like skin changes inside the circular arrangement of the papules. At the scar-like tissue, we found electron-microscopical evidence of randomly aggregated thin collagen fibers with no tendency toward systemic combined bundle formation, which is a characteristic feature of normal collagen fiber formation. Pseudoxanthoma-elasticum-like changes were observed on his neck. On his axillae and groin, slight skin thickening and wrinkling were detected. The diagnosis of elastosis perforans serpiginosa does not represent all of the manifestations or the pathological background described above. The skin manifestations described here represent not only an elastosis but also a total degenerative dermatosis with overhealed collagenosis. Thus, those dermatoses should be summarized as one entity, penicillamine-induced degenerative dermatosis. After considering the pathogenic background and clinical similarities, we further propose to simplify the penicillamine-induced skin manifestations to three categories: acute sensitivity reactions, bullous dermatoses, and degenerative dermatoses.
Iozumi
K
K
Department of Dermatology, Faculty of Medicine, University of Tokyo, Japan.
Nakagawa
H
H
Tamaki
K
K
D000328:Adult; D002614:Chelating Agents / Q000009:adverse effects*; D003094:Collagen / Q000648:ultrastructure; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D004547:Elastic Tissue / Q000187:drug effects / Q000473:pathology; D006527:Hepatolenticular Degeneration / Q000188:drug therapy; D006801:Humans; D008297:Male; D008854:Microscopy, Electron; D010396:Penicillamine / Q000009:adverse effects*
D002614:Chelating Agents; D003094:Collagen; D010396:Penicillamine